Internal Medicine Doctors in Portsmouth, VA Accepting Medicare
88 Internal Medicine doctors found. Showing 81 - 88
 Dr. Rasheed Hassan, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Circle, Internal Medicine Division, Portsmouth, VA 23708 Phone: 757-953-5397 |
Dr. Peter Alexander Beale, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2277 |
Dr. Kevin Lee Gallagher, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-9361 Fax: 757-953-0477 |
 Dr. Antonietta Mancao Castanares, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 3235 Academy Ave, Suite 301, Portsmouth, VA 23703 Phone: 757-484-9400 Fax: 757-484-8809 |
Dr. Stacy Lauren Coulthard, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-4455 |
Amie Luann Harvey, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Circle, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-3149 |
Dr. Kevin David Wilson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3300 High St, Suite 6, Portsmouth, VA 23707 Phone: 757-399-4341 Fax: 757-393-0743 |
Dr. Christopher Mark Culp, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Naval Medical Center, 620 John Paul Jones Circle, Portsmouth, VA 23708 Phone: 757-953-0679 |
News Archive
Prenatal exposure to air pollution can be serious for children with asthma
The link between prenatal exposure to air pollution and childhood lung growth and respiratory ailments has been established by several studies in recent years, and now a new study suggests that these prenatal exposures can be especially serious for children with asthma.
Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.
'The Silent Treatment' research focuses on communication breakdown in hospitals
Health care professionals make calculated decisions daily to not alert their colleagues when a safety tool signals potential harm to a patient, according to a new study of 6,500 nurses and nurse managers released March 22 during a national briefing in Philadelphia.
FDA approves Medtronic's Complete SE Vascular Stent System for PAD
Broadening the scope of innovation for cardiovascular interventions beyond the heart, Medtronic, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the Complete® SE Vascular Stent System to be used for the treatment of peripheral arterial disease (PAD) in the iliac arteries, major blood vessels within the pelvis that supply blood to the lower extremities.
Study reveals that nondrinkers have higher mortality risk than light drinkers
As a class, people who don't drink at all have a higher mortality risk than light drinkers. But nondrinkers are a diverse bunch, and the reasons people have for abstaining affects their individual mortality risk, in some cases lowering it on par with the risk for light drinkers, according to a University of Colorado study.
› Verified 9 days ago
Internal Medicine
Emergency Medicine
Anesthesiology
Pediatrics
Psychiatry & Neurology
Family Medicine
General Practice
Radiology
Surgery
Orthopaedic Surgery
Obstetrics & Gynecology